Viewing StudyNCT06463522



Ignite Creation Date: 2024-07-17 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06463522
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2024-04-26

Brief Title: Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma
Sponsor: Beijing 302 Hospital
Organization: Beijing 302 Hospital

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-07-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-07-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-04-26
First Submit QC Date: None
Study First Post Date: 2024-06-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-11
Last Update Post Date: 2024-06-17
Last Update Post Date Type: ACTUAL